Senior insider sale
Chief Medical Officer at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$1.25M
28.23K shares
What this filing means
INRIG JULA plans to sell 28.23K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $1.25M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/4/2026ACC: 0001950047-26-003946
Officer· Chief Medical Officer
Since Jan 2022
28.23K
Shares to sell
$1.25M
Approx. market value
20K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
5/4/2026
20KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/4/2026 | Stock Option Exercise Cash | 20K | — |
| Total | 20K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.02K
Market value
$43.4K
4/15/2026
—Completed
Units to sell
7.21K
Market value
$302.5K
4/14/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
20K
Market value
$900.0K
5/4/2026
Total
Units
28.23K
Value
$1.25M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/15/2026 | 1.02K | $43.4K | — | Completed |
4/14/2026 | 7.21K | $302.5K | — | Completed |
| Planned — Approximate Date | ||||
5/4/2026 | 20K | $900.0K | NASDAQ | Planned |
| Total | 28.23K | $1.25M | ||